rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPHARM Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 14 Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10
Sources of funds
Owner's fund
Equity share capital 18.66 18.66 18.38 17.48 15.98
Share application money - 3.13 5.87 2.74 -
Preference share capital - - - - -
Reserves & surplus 50.12 45.66 39.64 33.97 25.02
Loan funds
Secured loans 99.34 91.92 80.65 51.05 29.76
Unsecured loans - - - - 0.04
Total 168.12 159.36 144.54 105.24 70.80
Uses of funds
Fixed assets
Gross block 78.31 78.83 81.64 40.84 37.32
Less : revaluation reserve - - - - -
Less : accumulated depreciation 15.37 12.43 11.82 7.46 5.19
Net block 62.93 66.40 69.82 33.38 32.13
Capital work-in-progress - - - 13.66 6.39
Investments 1.43 1.43 1.43 - -
Net current assets
Current assets, loans & advances 158.23 175.11 136.11 87.57 44.10
Less : current liabilities & provisions 54.47 83.58 62.82 30.39 13.33
Total net current assets 103.76 91.53 73.29 57.19 30.77
Miscellaneous expenses not written - - - 1.01 1.51
Total 168.12 159.36 144.54 105.24 70.80
Notes:
Book value of unquoted investments 1.43 1.43 1.43 - -
Market value of quoted investments - - - - -
Contingent liabilities 18.24 14.07 - - -
Number of equity sharesoutstanding (Lacs) 186.56 186.56 183.81 174.81 159.81
Close
Add Bafna Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bafna Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close